Luisa Salter-Cid
Corporate Officer/Principal en Flagship Pioneering .
Perfil
Luisa Salter-Cid is currently the Chief Scientific Officer & Pioneering Medicines at Flagship Pioneering.
Prior to this, she was the Director at Jounce Therapeutics, Inc. from 2021 to 2023, the Chief Scientific Officer at Gossamer Bio, Inc. from 2018 to 2021, and the Vice President & Head-Immunology at Bristol Myers Squibb Co. from 2005 to 2018.
Dr. Salter-Cid has a graduate degree from Florida International University, an undergraduate degree from the University of Lisbon, and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Cargos activos de Luisa Salter-Cid
| Empresas | Cargo | Inicio |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 01/01/2021 |
Antiguos cargos conocidos de Luisa Salter-Cid.
| Empresas | Cargo | Fin |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Director/Miembro de la Junta | 03/05/2023 |
| GOSSAMER BIO, INC. | Director Técnico/Científico/I+D | 30/04/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/08/2018 |
Formación de Luisa Salter-Cid.
| University of Lisbon | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
| Florida International University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GOSSAMER BIO, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Empresas privadas | 2 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Bolsa de valores
- Insiders
- Luisa Salter-Cid
